A, Ö., K, d. J., E, K., M, S., S, Z., F, v. d. B., . . . NA, d. G. (2025). Response to letter Re: Impact of immune-related adverse events on quality of life and physical functioning in older patients with solid tumors treated with immune checkpoint inhibitors. European journal of cancer (Oxford, England : 1990), 230, 115800. https://doi.org/10.1016/j.ejca.2025.115800
Chicago Style (17th ed.) CitationA, Özkan, et al. "Response to Letter Re: Impact of Immune-related Adverse Events on Quality of Life and Physical Functioning in Older Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors." European Journal of Cancer (Oxford, England : 1990) 230 (2025): 115800. https://doi.org/10.1016/j.ejca.2025.115800.
MLA (9th ed.) CitationA, Özkan, et al. "Response to Letter Re: Impact of Immune-related Adverse Events on Quality of Life and Physical Functioning in Older Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors." European Journal of Cancer (Oxford, England : 1990), vol. 230, 2025, p. 115800, https://doi.org/10.1016/j.ejca.2025.115800.
